Metabolic mapping with cellular resolution: c-fos vs. 2-deoxyglucose

Mapping metabolic activity in the nervous system has long relied on tools like 2-deoxyglucose (2DG), which captures glucose metabolism in activated regions. While 2DG provides useful spatial data, its ability to resolve activity at the cellular level has been limited. In contrast, immediate early genes (IEGs) like c-fos offer a complementary approach by marking transcriptional responses to diverse stimuli. These genes are activated rapidly in response to various intracellular signals, including synaptic activity, stress, and growth factors. Their nuclear localization and broad induction patterns make them valuable for identifying cells that respond to metabolic or physiological changes. Prior research has shown that IEGs can be induced in neurons and glial cells by a range of stimuli, from sensory inputs to hormonal signals. However, the extent to which these genes can distinguish between different types of cellular activity remains unclear. The ability to detect glial responses has been particularly limited, as traditional methods often focus on neurons. This gap motivated further investigation into the utility of IEGs for cellular-level metabolic mapping.

This study aimed to compare the utility of two metabolic mapping techniques—2-deoxyglucose (2DG) and c-fos gene expression—in identifying activated cells within the nervous system. The goal was to determine whether these methods could complement each other in capturing different aspects of metabolic activity. The focus was on how each method reflects synaptic activation and how they differ in their cellular specificity. The study also sought to clarify whether c-fos could detect glial responses that 2DG might miss. By examining the effects of various stimuli, including growth factors and sensory inputs, the researchers aimed to assess the reliability of c-fos as a marker of cellular activation. The comparison was particularly relevant for understanding how metabolic changes are distributed across neurons and glia. The study's design allowed for direct comparisons between the spatial and cellular resolution of each method. The ultimate aim was to evaluate whether c-fos could serve as a more precise tool for identifying activated cells at the single-cell level.

The study employed both 2DG and c-fos gene expression as tools for mapping metabolic activity. 2DG was used to detect glycolytic glucose metabolism in presynaptic neurons and possibly glial cells. c-fos expression was analyzed to identify cells undergoing transcriptional activation in response to various stimuli. The researchers examined the effects of osmotic pressure, bacterial endotoxin, and steroid hormones on c-fos induction. They also tested sensory stimuli like light and auditory signals. Growth factors such as epidermal growth factor (EGF) and transforming growth factor-alpha (TGF-alpha) were administered to assess glial responses. The localization of c-fos was determined using nuclear immunostaining. The study compared the spatial and cellular resolution of each method in detecting activated cells. The use of multiple stimuli allowed for a broad assessment of the conditions under which each method could detect metabolic changes.

The study found that 2DG accumulation primarily reflected glycolytic glucose metabolism in presynaptic neurons and possibly glial cells. Increases in 2DG levels were consistent with synaptic activation but lacked cellular specificity. In contrast, c-fos expression was induced in neurons by a wide range of stimuli, including sensory inputs, stressors, and growth factors. The nuclear localization of c-fos made it a reliable marker of transcriptional activity in activated cells. c-fos was also induced in retinal Müller cells after intravitreal injection of EGF or TGF-alpha. This finding demonstrated that adult glial cells could respond to growth factors in vivo. The expression of c-fos was not limited to neurons but extended to glial cells. The study showed that c-fos could detect responses to both neuronal and glial stimuli. These results suggested that c-fos could serve as a more precise tool for identifying activated cells at the cellular level.

The authors concluded that c-fos gene expression is a useful tool for identifying cells that respond to a wide range of stimuli, including growth factors and sensory inputs. The nuclear localization of c-fos makes it a reliable marker of transcriptional activation in activated cells. The study demonstrated that c-fos could detect responses in both neurons and glial cells, particularly in retinal Müller cells exposed to growth factors. This finding suggests that c-fos may be more sensitive than 2DG in detecting glial responses to metabolic changes. The comparison between the two methods revealed that c-fos could provide higher cellular resolution than 2DG. The study proposed that c-fos could be particularly useful in investigating the role of trophic factors in cellular responses to injury. The authors suggested that further research could explore the utility of c-fos in mapping metabolic activity in different parts of the nervous system. These findings support the use of c-fos as a complementary tool to 2DG in metabolic mapping studies.